Literature DB >> 16052847

Hepatitis B and measles seroprevalence among Turkish children.

Güler Kanra1, Sabahat Tezcan, Selim Badur.   

Abstract

This study was performed to determine hepatitis B and measles seroprevalence among the population under 30 years of age in Turkey. Blood samples of 2,683 subjects from eight provinces of Turkey were studied. Measles IgG was determined by hemagglutinin inhibition method, and hepatitits B surface antigen (HBsAg), anti-hepatitis B surface antibody (anti-HBs) and anti-hepatitis B core antibodies (anti-HBc) were determined by ELISA method. Overall seropositivity for measles was found to be 59.6%. There was a significant difference in seropositivity among provinces. The seropositivity was found to increase with age. The overall seropositivities for HBsAg, anti-HBs and anti-HBc were found to be 5.4%, 17% and 15.1%, respectively. The seroprevalences differed significantly among provinces. Although seroprevalence for anti-HBs and anti-HBc increased with age, HBsAg seropositivity did not change significantly after one year of age. Seroprevalence was not affected by sex. It was concluded that every effort should be given to vaccinate infants as early as possible for hepatitis B and that the coverage of infancy measles vaccination should be increased with a second dose.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052847

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  8 in total

1.  Long-term prognosis of chronic hepatitis B virus infection in the childhood.

Authors:  Ulaş Emre Akbulut; Murat Çakır
Journal:  Turk Pediatri Ars       Date:  2014-06-01

2.  Chronic hepatitis B in children with or without malignancies: a 13-year follow-up.

Authors:  Merve Usta; Nafiye Urgancı; Zeynep Yıldız Yıldırmak; Sema Dogan Vural
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

3.  Missed opportunities for Hepatitis B vaccination among diabetic patients.

Authors:  Lale Ozisik; Mine Durusu Tanriover; Nursel Calik Basaran; S Gul Oz; Serhat Unal
Journal:  Hum Vaccin Immunother       Date:  2015-09-14       Impact factor: 3.452

4.  Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis.

Authors:  Figen Çakmak; Mustafa Çakan; Ferhat Demir; Hafize Emine Sonmez; Sedat Çakmak; Fatma Gul Demirkan; Şerife Gül Karadağ; Nuray Aktay Ayaz; Betül Sözeri
Journal:  Rheumatol Int       Date:  2021-03-18       Impact factor: 2.631

5.  Seroprevalence of Hepatitis B and C among Children in Endemic Areas of Turkey.

Authors:  Murat Kangin; Mine Turhanoglu; Serda Gulsun; Bahri Cakabay
Journal:  Hepat Mon       Date:  2010-03-01       Impact factor: 0.660

Review 6.  Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review.

Authors:  Mehlika Toy; Fatih Oguz Önder; Tanja Wörmann; A Mithat Bozdayi; Solko W Schalm; Gerard J Borsboom; Joost van Rosmalen; Jan Hendrik Richardus; Cihan Yurdaydin
Journal:  BMC Infect Dis       Date:  2011-12-12       Impact factor: 3.090

Review 7.  Epidemiology of Chronic Hepatitis B in Turkey.

Authors:  Hasan Özkan
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

8.  Seroprevalence of Hepatitis B, Hepatitis C, and HIV in children with cancer at diagnosis and following therapy in Turkey: progress within the last 25 years.

Authors:  Rejin Kebudi; Tarkan Agasoy; Hande Kizilocak; Gül Nihal Ozdemir
Journal:  Turk Pediatri Ars       Date:  2019-07-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.